OrbiMed Royalty and Credit Opportunities III

OrbiMed Royalty and Credit Opportunities III is a private investment fund managed by OrbiMed, a premier healthcare investment firm. The fund focuses on providing non-dilutive capital to late-stage biopharmaceutical, medical device, and diagnostic companies through royalty monetizations and structured credit facilities. With a diversified portfolio across the healthcare sector, the fund aims to support companies in financing clinical trials, product launches, and strategic acquisitions. It typically targets investments ranging from $20 million to several hundred million dollars per transaction. By leveraging OrbiMed's deep scientific and financial expertise, the fund provides flexible financing solutions tailored to the unique needs of healthcare innovators.